COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,797 Articles (22,527 medRxiv, 8,270 bioRxiv)

Most recent first Previous |  Page 1163: Articles 11621-11630  | Next

Effectiveness of mRNA-1273 against Delta, Mu, and other emerging variants
Bruxvoort, K., Sy, L. S., Qian, L., Ackerson, B. K., Luo, Y., Lee, G. S., Tian, Y., Florea, A., Aragones, M., Tubert, J. E., Takhar, H. S., Ku, J. H., Paila, Y. D., Talarico, C. A., Tseng, H. F.
10.1101/2021.09.29.21264199 — Posted: 2021-10-01
Reduced amplification efficiency of the RNA-dependent-RNA-polymerase (RdRp) target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests
Valley-Omar, Z., Marais, K., Iranzadeh, A., Naidoo, M., Korsman, S., Maponga, T., Hussey, H., Davies, M.-A., Boulle, A., Doolabh, D., Laubscher, M., Deetlefs, J., Maritz, J., Scott, L., Msomi, N., Tegally, H., de Oliveira, T., Bhiman, J., Williamson, C., Preiser, W., Hardie, D. R., Hsiao, N.-y.
10.1101/2021.10.01.21264408 — Posted: 2021-10-01
Evaluation of liver function tests and C-reactive protein in COVID-19 (SARS Cov-2) positive patients diagnosed by Real-time PCR
Khurshid, F., Iqbal, S., Mumtaz, M.
10.1101/2021.09.29.21264304 — Posted: 2021-10-01
Endemic Seasonal Coronavirus Neutralisation and COVID-19 severity
Wells, D. A., Cantoni, D., Mayora-Neto, M., Di Genova, C., Sampson, A., Ferrari, M., Carnell, G., Nadesalingam, A., Smith, P., Chan, A., Raddi, G., Castillo-Olivares, J., Baxendale, H., Temperton, N., Heeney, J.
10.1101/2021.09.29.21264328 — Posted: 2021-10-01
Mini-XT, a miniaturized tagmentation-based protocol for efficient sequencing of SARS-CoV-2
Fuchs, M., Radulescu, C., Tang, M., Mahesh, A., Lavin, D., Umbreen, S., McKenna, J., Smyth, M., McColgan, E., Molnar, Z., Baxter, C., Skvortsov, T., Singh, A., Rogan, F., Miskelly, J., Bridgett, S., Fairley, D., Simpson, D. A.
10.1101/2021.09.29.21263685 — Posted: 2021-10-01
The importance of semantic network brain regions in integrating prior knowledge with an ongoing dialogue
Raykov, P. P., Keidel, J. L., Oakhill, J., Bird, C. M.
10.1101/276683 — Posted: 2021-10-01
Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom
Perez-Lloret, S., Petrovsky, N., Alami, A., Crispo, J., Mattison, D., Otero-Losadsa, M., Capani, F., Krewski, D.
10.1101/2021.09.28.21264245 — Posted: 2021-10-01 Discussion: Onsite
Ad26.COV2.S Prevents SARS-CoV-2 Induced Pathways of Inflammation and Thrombosis in Hamsters
Aid, M., Vidal, S., Piedra-Mora, C., Ducat, S., Chan, C., Bondoc, S., Colarusse, A., Starke, C., Nekorchuk, M., Busman-Sahay, K., Estes, J., Martinot, A., Barouch, D. H.
10.1101/2021.09.30.462514 — Posted: 2021-09-30
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
Reincke, S. M., Yuan, M., Kornau, H.-C., Corman, V. M., van Hoof, S., Sanchez-Sendin, E., Ramberger, M., Yu, W., Hua, Y., Tien, H., Schmidt, M. L., Schwarz, T., Jeworowski, L. M., Brandl, S. E., Foverskov Rasmussen, H., Homeyer, M. A., Stöffler, L., Barner, M., Kunkel, D., Huo, S., Horler, J., Wardenburg, N. v., Kroidl, I., Eser, T. M., Wieser, A., Geldmacher, C., Hoelscher, M., Gänzer, H., Weiss, G., Schmitz, D., Drosten, C., Prüss, H., Wilson, I. A., Kreye, J.
10.1101/2021.09.30.462420 — Posted: 2021-09-30
Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice
Paschall, A. V., Ozdilek, A., Briner, S. L., Brindley, M. A., Avci, F.
10.1101/2021.09.28.462156 — Posted: 2021-09-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).